|
CA2261619C
(en)
*
|
1996-07-26 |
2006-05-23 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
ES2249511T3
(es)
*
|
1997-07-25 |
2006-04-01 |
Gilead Sciences, Inc. |
Composiciones de analogos de nucleotido y procedimiento de sintesis.
|
|
EP1243590B1
(en)
*
|
1997-07-25 |
2005-02-09 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
|
PT1256584E
(pt)
*
|
1997-07-25 |
2004-12-31 |
Gilead Sciences Inc |
Processo para a preparacao de adefovir-dipivoxil
|
|
MXPA00012842A
(es)
*
|
1998-06-24 |
2004-06-22 |
Univ Emory |
Uso de 3'-azido-2',3'-didesoxiuridina en combinacion de drogas adicionales contra el vih para la manufactura de un medicamento para el tratamiento del vih.
|
|
CZ304734B6
(cs)
*
|
2000-07-21 |
2014-09-10 |
Gilead Sciences, Inc. |
Způsob přípravy 9-[2-(fosfonomethoxy)propyl]adeninu a 9-[2-(fosfonomethoxy)ethyl]adeninu
|
|
AU2003231765B9
(en)
|
2002-04-26 |
2010-01-28 |
Gilead Sciences, Inc. |
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
|
|
MXPA05007016A
(es)
|
2003-01-14 |
2005-09-12 |
Gilead Sciences Inc |
Composiciones y metodos para terapia antiviral de combinacion.
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
EP2359833A1
(en)
|
2003-04-25 |
2011-08-24 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
|
US7273716B2
(en)
|
2003-04-25 |
2007-09-25 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds with GS-7340 ester hydrolase
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
MXPA05011296A
(es)
|
2003-04-25 |
2006-01-24 |
Gilead Sciences Inc |
Conjugados de fosfonato inhibidores de la cinasa.
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
DE602004031115D1
(de)
|
2003-06-16 |
2011-03-03 |
Acad Of Science Czech Republic |
Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
|
|
WO2005044308A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
|
WO2005063751A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
|
CA2548951A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
ME03423B
(me)
|
2004-07-27 |
2020-01-20 |
Gilead Sciences Inc |
Fosfonatni analozi jedinjenja hiv inhibitora
|
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
WO2006133632A1
(fr)
*
|
2005-06-13 |
2006-12-21 |
Brightgene Bio-Medical Technology Co., Ltd. |
Promedicament analogue nucleotidique et sa preparation
|
|
EP2420238A3
(en)
|
2007-04-13 |
2012-03-07 |
Southern Research Institute |
Anti-angiogenic agents
|
|
JP2010527996A
(ja)
*
|
2007-05-22 |
2010-08-19 |
ウルティモルフィクス・テクノロジーズ・ベー・フェー |
テノホビルジソプロキシル−ヘミフマル酸共結晶
|
|
WO2009064174A1
(en)
*
|
2007-11-14 |
2009-05-22 |
Ultimorphix Technologies B.V. |
Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
|
|
NZ588796A
(en)
*
|
2008-04-25 |
2012-07-27 |
Cipla Ltd |
Crystalline form of tenofovir disoproxil and a process for its preparation
|
|
UA103329C2
(ru)
|
2008-07-08 |
2013-10-10 |
Гилиад Сайенсиз, Инк. |
Соли соединений-ингибиторов вич
|
|
CN102093422B
(zh)
|
2009-12-10 |
2015-02-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
无环核苷膦酸酯衍生物及其医药用途
|
|
US20140073607A1
(en)
*
|
2011-05-10 |
2014-03-13 |
Okapi Sciences Nv |
Compounds for use in the treatment of feline retroviral infections
|
|
HRP20161696T4
(hr)
|
2011-08-16 |
2023-10-13 |
Gilead Sciences, Inc. |
Tenofovir alafenamid hemifumarat
|
|
CN103626802A
(zh)
*
|
2012-08-23 |
2014-03-12 |
重庆药友制药有限责任公司 |
一种制备替诺福韦的新方法
|
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
|
CA2889903C
(en)
|
2012-10-29 |
2021-03-09 |
Manjinder Singh Phull |
Antiviral phosphonate analogues and process for preparation thereof
|
|
PT2860184T
(pt)
|
2013-10-09 |
2018-11-20 |
Zentiva Ks |
Sal de di-hidrogenofosfato de tenofovir disoproxil
|
|
EP2860185A1
(en)
|
2013-10-09 |
2015-04-15 |
Zentiva, k.s. |
An improved process for the preparation of Tenofovir disoproxil and pharmaceutically acceptable salts thereof
|
|
TWI660965B
(zh)
*
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
泰諾福韋之固體形式
|
|
SI3661937T1
(sl)
|
2017-08-01 |
2021-11-30 |
Gilead Sciences, Inc. |
Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
|
|
CN107805202A
(zh)
*
|
2017-12-01 |
2018-03-16 |
内蒙古圣氏化学股份有限公司 |
一种氯甲基异丙基碳酸酯连续化反应装置及方法
|